Further verification of these genes in epinephrine-treated cells showed that SLUG, a key regulatory factor in breast cancer stemness (25), exhibited the greatest increase in cells following epinephrine treatment (Figure 2B). This evidence concerns the gene SNAI2 and breast carcinoma.